Elite Express Granted Additional Nasdaq Compliance Cure Period

Elite Express Holding Inc. Class A ( (ETS) ) just unveiled an update.

On October 31, 2025, Elite Express Holding Inc. was notified by Nasdaq that its shares had traded below the $1.00 minimum bid price for 30 consecutive business days, putting the company out of compliance with Nasdaq’s listing rules and triggering an initial 180-day cure period through April 29, 2026. On April 30, 2026, Nasdaq granted the company a second 180-day compliance period, until October 26, 2026, after determining it met all other initial listing requirements and had signaled its willingness to consider a reverse stock split if needed to restore its share price.

The company’s stock will continue to trade on The Nasdaq Capital Market while it monitors its bid price and evaluates options to regain compliance, including a potential reverse split at a ratio previously approved by shareholders. If Elite Express fails to lift its closing bid price to at least $1.00 for 10 consecutive business days by October 26, 2026, its securities will become subject to delisting, heightening the risk profile for investors and potentially affecting the company’s market visibility and liquidity.

More about Elite Express Holding Inc. Class A

Elite Express Holding Inc. is a publicly traded company listed on The Nasdaq Capital Market. The company’s securities are subject to Nasdaq’s continued listing standards, including minimum bid price and market value of publicly held shares requirements that govern its access to public equity markets.

Average Trading Volume: 104,844

Technical Sentiment Signal: Hold

Current Market Cap: $8.04M

See more data about ETS stock on TipRanks’ Stock Analysis page.